MIR1179: A Drug Target / Disease Biomarker (G100302235)
MIR1179: A Drug Target / Disease Biomarker
MIR1179 is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, kidneys, and intestines. It is a member of the Mir1 family of transmembrane proteins, which are known for their role in cell signaling.
One of the unique features of MIR1179 is its ability to interact with multiple signaling pathways, including TGF-β, NF-kappa-B, and PI3K/AKT. This makes it an attractive target for researchers who are looking for new drugs or biomarkers that can modulate these pathways.
MIR1179 has also been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that MIR1179 is overexpressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that targeting MIR1179 may be a promising strategy for the development of new cancer therapies.
In addition to its potential as a drug target, MIR1179 has also been shown to be a useful biomarker for several diseases. For example, researchers have used MIR1179 as a marker to track the progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that MIR1179 may be a useful diagnostic tool for these conditions.
Another application of MIR1179 is its potential as a target for drug discovery. Researchers have used various techniques to identify small molecules that can interact with MIR1179, including high-throughput screening assays and yeast two-hybrid assays. These studies have identified several potential drug candidates that may be able to modulate MIR1179 activity.
In conclusion, MIR1179 is a protein that has the potential to be a drug target or biomarker in several diseases. Its ability to interact with multiple signaling pathways and its involvement in several diseases make it an attractive target for researchers who are looking for new therapies or biomarkers. Further research is needed to fully understand the role of MIR1179 in disease and to develop effective therapies.
Protein Name: MicroRNA 1179
The "MIR1179 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1179 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284
